Atlas Trials

MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtib

Clinical trial NCT03865511 · UNKNOWN

Trial details

NCT number
NCT03865511
Sponsor
Nantes University Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2019-04-09
Primary completion
2025-01-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.